RecruitingNot applicableNCT07499284

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: The First Affiliated Hospital of Soochow University
Principal Investigator: Depei Wu
The First Affiliated Hospital of Soochow University
Intervention: Haploidentical hematopoietic cell transplantation combined with unrelated cord blood stem cells(procedure)
Enrollment: 224 enrolled
Eligibility: 14 years · All sexes
Timeline: 2025 – 2028

Study locations (4)

Hematology Department, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Suzhou Hongci Hematology Hospital, Suzhou, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07499284 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia →

← Back to all trials